KPMTech will conduct a third-party allotment capital increase worth approximately 22.5 billion won, targeting its majority shareholder TelconRF Pharmaceutical.

According to KPMTech's regulatory filing on the 3rd, the new shares to be issued through this capital increase total 6,200,055 common shares. The issue price per share is 3,629 won, bringing the total amount to be raised to 22,499,999,595 won.

Use of Proceeds: Debt Repayment and Acquisition of 'New On' The company has clearly outlined its plan for the use of proceeds. Eight billion won of the funds will be allocated to repaying existing debt, while the remaining 14,499,999,595 won will be used to acquire securities of another corporation. The company specified 'New On' as the target entity for acquisition, although the specific acquisition price has not yet been determined.

The company explained that the proceeds from this capital increase will consist of a cash contribution from TelconRF Pharmaceutical (14,499,999,595 won) and an in-kind contribution (offset treatment) for existing debt (8 billion won).

• *Key Schedule and Issuance Method**
• Payment Date: July 13
• New Share Listing Date: July 27

The new shares will be issued through a private placement and will be placed under lock-up for one year from the date of share certificate delivery, restricting immediate circulation in the market.

Background on Selection of Allotment Recipient Regarding the reason for selecting its majority shareholder TelconRF Pharmaceutical as the third-party allotment recipient, the company stated, "The board of directors made the decision considering the investor's intention, payment capability, and timing in order to achieve the company's management objectives and secure swift funding."